Expression of Ki-67 and CD34 on blood and bone marrow cells of CML patients with different response to imatinib and nilotinib therapy
Summary. Aim: To assess the expression of Ki-67 protein and CD34 antigen on peripheral blood (PB) and bone marrow (BM) cells in chronic myelogenous leukemia (CML) patients with different response to tyrosine kinase inhibitors (TKI) imatinib (IM) and nilotinib (NI) therapy. Patients...
Gespeichert in:
| Datum: | 2023 |
|---|---|
| Hauptverfasser: | Perekhrestenko, T., Melnyk, U., Goryainova, N., Diagil, I. |
| Format: | Artikel |
| Sprache: | English |
| Veröffentlicht: |
PH Akademperiodyka
2023
|
| Schlagworte: | |
| Online Zugang: | https://exp-oncology.com.ua/index.php/Exp/article/view/2020-2-3 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Назва журналу: | Experimental Oncology |
Institution
Experimental OncologyÄhnliche Einträge
-
Aberrant expression of placental-like alkaline phosphatase in chronic myeloid leukemia cells in vitro and its modulation by vitamin E
von: Shvachko, L.P., et al.
Veröffentlicht: (2023) -
The Kі-67 marker for assessing the effectiveness of systemic or regional neoadjuvant polychemotherapy in patients with locally advanced breast cancer
von: Dumanskiy, Y.V., et al.
Veröffentlicht: (2023) -
The role of the genetic abnormalities, epigenetic and microRNA in the prognosis of chronic lymphocytic leukemia
von: Tari, K., et al.
Veröffentlicht: (2018) -
Assessment of trace elements in serum of acute lymphoblastic and myeloid leukemia patients
von: Valadbeigi, S., et al.
Veröffentlicht: (2023) -
Vitamin Е activates expression of С/EBP alpha transcription factor and G-CSF receptor in leukemic K562 cells
von: Shvachko, L.P., et al.
Veröffentlicht: (2018)